Description
Achieve clearer, smoother, and more balanced skin with Idyllic Cleanser. This professional-grade cleanser is designed for daily use to gently exfoliate, reduce breakouts, and brighten the complexion without irritation.
Formulated with 3% mandelic acid, this cleanser helps remove dead skin cells and promote healthy cell turnover. Mandelic acid is a gentle alpha hydroxy acid (AHA) with a larger molecular structure, allowing it to work effectively while minimizing irritation. This makes it ideal for sensitive, acne-prone, or reactive skin.
This cleanser works to purify pores and reduce acne-causing bacteria, helping prevent future breakouts. It also helps control excess oil, refine skin texture, and improve overall clarity.
With regular use, the skin appears smoother, more even-toned, and refreshed. It helps reduce the appearance of dark spots and dullness while supporting a brighter, more radiant complexion.
The lightweight, refreshing formula cleanses effectively without over-drying the skin. It maintains balance while supporting the skin barrier, making it suitable for both corrective and preventative routines.
Idyllic Cleanser is also ideal for pre-treatment preparation and post-treatment maintenance. It helps improve product absorption and enhances the effectiveness of serums and moisturizers.
Suitable for all skin types and tones, including sensitive or rosacea-prone skin, this cleanser is a versatile addition to any skincare routine.
Benefits
- Deeply cleanses and purifies the skin
- Gently exfoliates to improve texture
- Helps reduce breakouts and prevent congestion
- Minimizes the appearance of pores
- Brightens and evens skin tone
- Supports preventative and post-treatment care
Skin Concerns
- Acne and breakouts
- Dark spots and hyperpigmentation
- Uneven texture and enlarged pores
- Sensitive or rosacea-prone skin
- Preventative aging
- Pre- and post-treatment care
Key Ingredients
- Mandelic Acid (3%) – Gently exfoliates, improves skin tone, and helps reduce acne






Reviews
There are no reviews yet.